Two Keynote Speakers confirmed for The Antibody Series 2025 Conference
The highly anticipated 2025 edition of the Antibody Series has confirmed two distinguished keynote speakers set to headline its Scientific Program.
Professor Annemiek van Spriel, a leading expert in immunology from Radboud University Medical Center, will deliver a keynote lecture titled “Tetraspanin microdomains: a novel target in B cell lymphoma”. Her groundbreaking research focuses on the role of tetraspanins in immune cell function and cancer, offering promising new directions for therapeutic strategies in lymphoma.
Joining her is Dr. Peter Senter, Vice President of Chemistry at Seagen Inc., who will present “Antibody-Drug Conjugates: From Bench to Bedside”. A pioneer in the development of ADCs, Dr. Senter will share insights into the evolution, challenges, and future of this transformative therapeutic approach.
The 2025 Antibody Series, set to gather the world’s leading minds in antibody R&D, promises cutting-edge discussions and collaboration. Full program details are available at antibodyseries.com.
Confirmed Keynote Speakers – The Antibody Series 2025
Two Keynote Speakers confirmed for The Antibody Series 2025 Conference The highly anticipated 2025 edition of the Antibody Series has confirmed two distinguished keynote speakers set to headline its Scientific Program. Professor Annemiek van Spriel, a leading expert in immunology from Radboud University Medical Center, will deliver a keynote lecture titled “Tetraspanin microdomains: a novel target in B cell lymphoma”. Her groundbreaking research focuses on the role of tetraspanins in immune cell function and cancer, offering promising new directions for therapeutic strategies
